Legend Biotech Corporation (LEGN) Financials

LEGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.6 billion 629.0 million
Dec. 31, 2025 1.7 billion 731.6 million
Sept. 30, 2025 1.7 billion 701.7 million
June 30, 2025 1.7 billion 654.4 million

LEGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -111.3 million ?
Dec. 31, 2025 -126.6 million 14.9 million
Sept. 30, 2025 23.8 million 15.0 million
June 30, 2025 -22.3 million 18.7 million

LEGN Net Income

No data available :(

LEGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 834.6 million - 112.1 million
Dec. 31, 2025 948.6 million - 94.6 million
Sept. 30, 2025 992.6 million 171.9 million 95.4 million
June 30, 2025 967.6 million 310.3 million 77.6 million

LEGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 92.6 million
Dec. 31, 2025 184.7 million
Sept. 30, 2025 184.6 million
June 30, 2025 184.1 million

LEGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 26.0 million 86.0 million 74.7 million -
Dec. 31, 2025 20.9 million 101.3 million 101.2 million 64.2 million
Sept. 30, 2025 5.0 million 113.1 million 87.3 million 52.6 million
June 30, 2025 9.2 million 98.3 million 80.6 million 48.1 million

LEGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 306.0 million 192.1 million
Dec. 31, 2025 306.4 million 123.5 million
Sept. 30, 2025 272.3 million 115.3 million
June 30, 2025 255.1 million 98.0 million

LEGN

Price: $35.75

52 week price:
16.24
45.30

Earnings Per Share: -1.38 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 302700

Market Capitalization: 6.7 billion

Links: